<DOC>
	<DOCNO>NCT02262975</DOCNO>
	<brief_summary>This study observational study conduct prospectively routine clinical set 1 year 700 patient diagnose Alzheimer 's disease treat donepezil ( Aricept ) monotherapy . The subject recruit select institution 8 country Asia .</brief_summary>
	<brief_title>A Multi-national Study Identify Treatment Discontinuation Rate de Novo Alzheimer 's Disease Patients Who Have Been Newly Prescribed With Donepezil ( Aricept ) Asia ( ADOS )</brief_title>
	<detailed_description>Participation study place additional visit schedule , determine investigator 's judgment base disease progression subject . Investigators educate subject keep decide visit schedule , collect require information case record ( CRF ) visit .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1 . Greater equal 50 year old less 90 year old 2 . Diagnosed probable AD base NINCDSADRDA 3 . Patients recently prescribe donepezil ( Aricept ) monotherapy 4 . Patients caregiver sign write informed consent use personal medical information 5 . Patients caregiver visit institution together 1 ) Patients take Memantine Acetylcholinesterase ( AChE ) inhibitor prior participate study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Alzheimer 's disease</keyword>
</DOC>